Parexel closes San Diego office, axes 3 and offers others work-from-home roles

Parexel building
Parexel shut down a San Diego office back in April. (Parexel)

Parexel shut down a San Diego office back in April, and three workers were axed while 37 others were offered work-from-home jobs.

This happened because there wasn’t enough use of the space. The company explained to FierceCRO: “In April 2019, Parexel closed our physical office in San Diego based on a review that showed low employee utilization of the available space over an extended period of time.

“Parexel provided our 37-local office-based employees flexible work-from-home arrangements to maintain our local presence while aligning our practices more closely with how our employees work today. A small number of roles, specifically our local Facilities and IT support, were eliminated based on the office closure.”

Webinar

How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDC

CROs are often at the forefront of adopting new technologies to make clinical trials more efficient. Hear how ICON, Lotus Clinical Research, and Bioforum are speeding database builds and automating reporting tasks for data management.

The closure was first made public in a recent WARN notice from California.

RELATED: Parexel nabs high-profile former FDA staffers, beefing up its regulatory offerings

This comes after fellow biopharma services company and rival Charles River Laboratories made a similar decision, cutting 24 employees from its San Diego site earlier this year. This also came out of a WARN notice, with the cuts confirmed to FierceCRO back in April, and staffers were relocated to a different site.

Suggested Articles

The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors digested the implications of the data.

The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.

While screening Caenorhabditis elegans for genetic clues to the PI3K/Akt signaling pathway, scientists found a key protein for insulin synthesis.